Agenus (NASDAQ: AGEN) revenue
Agenus reported revenue of $114.2m for fiscal 2025, 10.4% more than in fiscal 2024 ($103.5m). Since fiscal 2016 its revenue has grown by 405.9%, an average growth of 19.7% a year.
Agenus's best year of the last 10 was fiscal 2021. The biggest drop was in fiscal 2022, −66.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $114.2m | +10.4% | −$20.2m | −17.7% |
| 2024 | $103.5m | −33.8% | −$120.5m | −116.4% |
| 2023 | $156.3m | +59.5% | −$159.5m | −102.1% |
| 2022 | $98.0m | −66.8% | −$179.4m | −183.0% |
| 2021 | $295.7m | +235.3% | $25.7m | 8.7% |
| 2020 | $88.2m | −41.2% | −$117.2m | −133.0% |
| 2019 | $150.0m | +307.9% | −$70.1m | −46.7% |
| 2018 | $36.8m | −14.2% | −$123.8m | −336.6% |
| 2017 | $42.9m | +89.9% | −$103.8m | −242.1% |
| 2016 | $22.6m | — | −$107.5m | −476.1% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Agenus revenue compared with its sector
By revenue for its latest fiscal year, Agenus ranks 277th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Agenus, 10.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 275th | Gyre Therapeutics | $116.6m | 10.2% |
| 276th | OraSure Technologies | $115.0m | −38.1% |
| 277th | Agenus | $114.2m | 10.4% |
| 278th | Immunitybio | $113.3m | 668.3% |
| 279th | Anika Therapeutics | $112.8m | −5.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Agenus
- How much revenue did Agenus make in fiscal 2025?
- Agenus reported revenue of $114.2m for fiscal 2025, compared with $103.5m in fiscal 2024.
- How much has the revenue of Agenus grown?
- Between fiscal 2016 and fiscal 2025 it went from $22.6m to $114.2m: 405.9% more, an average growth of 19.7% a year.
- What was the best year for revenue at Agenus?
- Of its last 10 fiscal years, fiscal 2021, with $295.7m.
- Where does Agenus rank in its sector by revenue?
- It ranks 277th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Agenus come from?
- From the annual report (Form 10-K) that Agenus files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Agenus files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Agenus: the Agenus page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.